AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2023
Nov 9, 2023
32407_dirs_2023-11-08_b6b7c41d-d3a9-4d8d-82ea-523f1043d267.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2023-11-06
Reporting Person: Parikh Asit (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-06 | Common Stock | P | 1000 | $8.04 | Acquired | 48500 | Direct |
| 2023-11-07 | Common Stock | P | 4000 | $7.76 | Acquired | 52500 | Direct |
| 2023-11-08 | Common Stock | P | 2500 | $7.80 | Acquired | 55000 | Direct |
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12